Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2013 (2013), Article ID 784709, 6 pages
http://dx.doi.org/10.1155/2013/784709
Clinical Study

Short-Term Outcomes of KeraSys Patch Graft for Glaucoma Drainage Devices: A Case Series

1Ruiz Department of Ophthalmology and Visual Science, The University of Texas Medical School at Houston, 6431 Fannin Street, MSB 7.024, Houston, TX 77030, USA
2Department of Ophthalmology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, Mail Code 6230, San Antonio, TX 78229, USA
3Ophthalmology Department, Medical School, University of Puerto Rico, Medical Sciences Campus, P.O. Box 365067, San Juan, PR 00936, USA
4Robert Cizik Eye Clinic, 6400 Fannin Street, Suite 1800, Houston, TX 77030, USA

Received 31 January 2013; Accepted 14 February 2013

Academic Editor: David A. Wilkie

Copyright © 2013 Kundandeep S. Nagi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose. Tube-related exposure is a known complication of glaucoma drainage device (GDD) surgery. Our objective is to report the early (approximately 1 year) tube exposure rate of implants covered with a keraSys (IOP Inc., Costa Mesa, CA, USA) tissue reinforcement graft. Patients and Methods. A retrospective, noncomparative, consecutive case series of 42 eyes with GDD implantation with keraSys patch grafts was performed. Main outcome measurements included patch-related complications: patch exposure, tube exposure, wound dehiscence, and patch migration. Results. Forty-two eyes were followed for an average of months (range 1.0–32.3 months). Four (10%) eyes experienced patch-related complications: two with exposure 8 months postoperatively, one with exposure 13 months postoperatively, and one with exposure 4 weeks postoperatively. Conclusion. The effectiveness of the keraSys patch graft is limited by the higher than expected early exposure rate found in this case series. These results should be confirmed in other studies.